Total population | Gram-negative group | Control group | p | |
---|---|---|---|---|
Age | 69.6 ± 13.9 | 66.9 ± 10.7 | 69.8 ± 14.0 | 0.273 |
Male sex | 63.1 % | 76.7 % | 62.3 % | 0.120 |
BMI | 26.1 ± 5.6 | 26.5 ± 5.5 | 26.1 ± 5.6 | 0.675 |
Medical admission | 10.1 % | 40.0 % | 8.1 % | 0.000 |
Hypertension | 58.1 % | 66.7 % | 57.5 % | 0.329 |
Valvular disease | 5.9 % | 10.0 % | 5.6 % | 0.328 |
Coronary artery disease | 21.0 % | 26.7 % | 19.4 % | 0.438 |
Heart failure | 10.1 % | 10.0 % | 10.1 % | 0.982 |
COPD | 24.7 % | 33.4 % | 24.1 % | 0.261 |
Diabetes | 22.7 % | 33.4 % | 22.0 % | 0.155 |
Chronic kidney disease | 10.1 % | 23.4 % | 9.3 % | 0.018 |
Malignancy | 58.5 % | 43.4 % | 59.5 % | 0.086 |
Previous antifungal therapy | 11.7 % | 33.4 % | 10.3 % | 0.000 |
Infection(s) on admission | 9.5 % | 20.0 % | 8.8 % | 0.051 |